Technical Analysis for VNRX - VolitionRX Limited

Grade Last Price % Change Price Change
grade A 3.09 5.46% 0.16
VNRX closed up 5.46 percent on Friday, March 22, 2019, on 1.51 times normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Flat
See historical VNRX trend table...

Date Alert Name Type % Chg
Mar 22 50 DMA Support Bullish 0.00%
Mar 22 Crossed Above 20 DMA Bullish 0.00%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 22 Outside Day Range Expansion 0.00%
Mar 21 Calm After Storm Range Contraction 5.46%
Mar 20 Fell Below 20 DMA Bearish 5.82%
Mar 19 Crossed Above 20 DMA Bullish -2.83%
Mar 19 Calm After Storm Range Contraction -2.83%
Mar 19 NR7 Range Contraction -2.83%
Mar 18 20 DMA Resistance Bearish 3.00%

Older signals for VNRX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
VolitionRX Limited, a development stage life sciences company, focuses on developing cancer detection blood tests for detecting and diagnosing cancer and other diseases. It develops two blood tests in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides; and three blood tests in the NuQ-V family to detect cancer and nucleosomes containing specific histone variants. The company also develops nine blood tests in the NuQ-M family to detect cancer by detecting nucleosomes containing modified histones, the proteins that package, and order DNA into nucleosomes; and five blood tests in the NuQ-A family to detect cancer by detecting nucleosome-protein adducts, as well as offers research kits. It develops HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help appropriate therapy; NuQ Endo endometriosis test; and NuQ clinical diagnostic products. VolitionRX Limited is based in Singapore.
Cancer Biology Diseases Disease Molecular Biology
Is VNRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.45
52 Week Low 1.44
Average Volume 113,719
200-Day Moving Average 2.3731
50-Day Moving Average 2.8172
20-Day Moving Average 3.0685
10-Day Moving Average 3.087
Average True Range 0.2502
ADX 22.12
+DI 18.8007
-DI 22.4843
Chandelier Exit (Long, 3 ATRs ) 2.6994
Chandelier Exit (Short, 3 ATRs ) 3.4006
Upper Bollinger Band 3.3939
Lower Bollinger Band 2.7431
Percent B (%b) 0.53
BandWidth 21.20906
MACD Line 0.0541
MACD Signal Line 0.0881
MACD Histogram -0.034
Fundamentals Value
Market Cap 81.94 Million
Num Shares 26.5 Million
EPS -0.52
Price-to-Earnings (P/E) Ratio -5.94
Price-to-Sales 0.00
Price-to-Book 3.88
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.62
Resistance 3 (R3) 3.58 3.36 3.53
Resistance 2 (R2) 3.36 3.23 3.38 3.50
Resistance 1 (R1) 3.23 3.15 3.30 3.27 3.47
Pivot Point 3.01 3.01 3.05 3.03 3.01
Support 1 (S1) 2.88 2.88 2.95 2.92 2.71
Support 2 (S2) 2.66 2.80 2.68 2.68
Support 3 (S3) 2.53 2.66 2.65
Support 4 (S4) 2.57